LOCKE; Kenneth Walter

Patent Applications and Registrations

Patent applications and USPTO patent grants for LOCKE; Kenneth Walter.The latest application filed is for "selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging".

Company Profile

0.17.15

LOCKE; Kenneth Walter - San Diego CA
Locke; Kenneth Walter - Carlsbad CA
Locke; Kenneth Walter - Littleton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Selective, Lipophilic, And Long-acting Beta Agonist Monotherapeutic Formulations And Methods For The Cosmetic Treatment Of Adiposity And Contour Bulging App 20170135923 - DOBAK; John Daniel ; et al.	2017-05-18
Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging Grant 9,597,531 - Dobak , et al. March 21, 2	2017-03-21
Methods for administration and formulations for the treatment of regional adipose tissue Grant 9,452,132 - Dobak , et al. September 27, 2	2016-09-27
Methods For Administration And Formulations For The Treatment Of Regional Adipose Tissue App 20160256418 - DOBAK; John Daniel ; et al.	2016-09-08
Method Of Treatment For Body Contouring App 20160089346 - Locke; Kenneth Walter	2016-03-31
Methods For Administration And Formulations For The Treatment Of Regional Adipose Tissue App 20150328146 - DOBAK; John Daniel ; et al.	2015-11-19
Methods for administration and formulations for the treatment of regional adipose tissue Grant 9,132,084 - Dobak , et al. September 15, 2	2015-09-15
Methods for administration and formulations for the treatment of regional adipose tissue Grant 8,404,750 - Dobak , et al. March 26, 2	2013-03-26
Selective, Lipophilic, and Long-Acting Beta Agonist Monotherapeutic Formulations and Methods for the Cosmetic Treatment of Adiposity and Contour Bulging App 20120178819 - Dobak; John Daniel ; et al.	2012-07-12
Methods for Administration and Formulations for the Treatment of Regional Adipose Tissue App 20120046257 - Dobak; John Daniel ; et al.	2012-02-23
Phenoxyalkylcarboxylic acid derivatives in the treatment of irritable bowel syndrome Grant 8,026,282 - Locke , et al. September 27, 2	2011-09-27
Lyophilized Cake Formulations App 20110224176 - Dobak; John Daniel ; et al.	2011-09-15
Methods For Administration And Formulations For The Treatment Of Regional Adipose Tissue App 20110130373 - Dobak; John Daniel ; et al.	2011-06-02
Phenoxyalkylcarboxylic Acid Derivatives In The Treatment Of Irritable Bowel Syndrome App 20100285074 - Locke; Kenneth Walter ; et al.	2010-11-11
Phenoxyalkycarboxylic acid derivatives in the treatment of ulcerative colitis Grant 7,786,169 - Locke , et al. August 31, 2	2010-08-31
Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propyl- phenoxy]butyric acid and methods of use Grant 7,728,169 - Locke , et al. June 1, 2	2010-06-01
Pharmaceutical Compositions Of Isolated Orthorhombic Crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propyl- Phenoxy]butyric Acid And Methods Of Use App 20080292698 - LOCKE; Kenneth Walter ; et al.	2008-11-27
Phenoxyalkycarboxylic acid derivatives in the treatment of interstitial cystitis Grant 7,429,617 - Locke , et al. September 30, 2	2008-09-30
Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propyl- phenoxy]butyric acid and methods of use Grant 7,365,224 - Locke , et al. April 29, 2	2008-04-29
Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propyl- phenoxy]butyric acid Grant 7,153,993 - Locke , et al. December 26, 2	2006-12-26
Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propyl- phenoxy]butyric acid and methods of use App 20060135604 - Locke; Kenneth Walter ; et al.	2006-06-22
Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propyl- phenoxy]butyric acid and methods of use Grant 7,064,146 - Locke , et al. June 20, 2	2006-06-20
Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propyl- phenoxy]butyric acid Grant 7,060,854 - Locke , et al. June 13, 2	2006-06-13
Process for making polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propyl- phenoxy] butyric acid App 20060106105 - Locke; Kenneth Walter ; et al.	2006-05-18
Phenoxyalkycarboxylic acid derivatives in the treatment of inflammatory diseases App 20050239902 - Locke, Kenneth Walter ; et al.	2005-10-27
Polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenyl- thio)propoxy]-2-propylphenoxy]butyric acid App 20040266878 - Locke, Kenneth Walter ; et al.	2004-12-30
Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydr- oxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid App 20040267041 - Locke, Kenneth Walter ; et al.	2004-12-30
Method of protecting brain tissue from cerebral infarction subsequent to ischemia Grant 5,801,160 - Sandage , et al. September 1, 1	1998-09-01
Dopamine D.sub.1 agonists for the treatment of dementia Grant 5,744,476 - Locke , et al. April 28, 1	1998-04-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.